Management of Placenta Accreta Spectrum

NCT ID: NCT04609527

Last Updated: 2020-11-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE2/PHASE3

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-10-16

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

placenta accreta spectrum is group of disorders which have a depate about the best way of management. this is a descriptive study about the best techniques to reduce morbidity and mortalities related to it.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

placenta accreta spectrum is group of disorders which have a depate about the best way of management. this is a descriptive study about the best techniques to reduce morbidity and mortalities related to it.

1. surgical management of placenta accreta
2. short term follow up to the outcomes
3. long term follow up

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Placenta Previa Placenta Accreta

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

All women with placenta praevia and previous scar in the uterus. Surgical management and follow up will be defined
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Management of placenta accreta spectrum

Conservative and radical (hysterectomy) treatment of placenta accreta. Follow up to the patients to detect the impact of treatment imposed A novel technique which early identification and repait of uterine wall defects resulted from invasion of the uterine wall by the placenta.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All placenta accreta e high possibility of placenta accrete
* consent
* easy follow up visits

Exclusion Criteria

* bleeding tendency
* associated medical disorder hypertension, diabetes, preeclapsia..
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Osama Saber Thabet Abdalmageed

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Osama Abdalmageed

Asyut, Non-US/Non-Canadian, Egypt

Site Status RECRUITING

Assiut University

Asyut, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Osama Abdalmageed

Role: CONTACT

01012234876

maha said

Role: CONTACT

01013464458

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Osama Abdalmageed

Role: primary

1007972027

Abdalmageed

Role: primary

1007972027

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Placenta Accreta

Identifier Type: -

Identifier Source: org_study_id